Industrial - Machinery
Compare Stocks
5 / 10Stock Comparison
THR vs HON vs EMR vs ROK vs TRMB
Revenue, margins, valuation, and 5-year total return — side by side.
Conglomerates
Industrial - Machinery
Industrial - Machinery
Hardware, Equipment & Parts
THR vs HON vs EMR vs ROK vs TRMB — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Industrial - Machinery | Conglomerates | Industrial - Machinery | Industrial - Machinery | Hardware, Equipment & Parts |
| Market Cap | $2.15B | $136.91B | $79.02B | $50.37B | $14.65B |
| Revenue (TTM) | $522M | $36.76B | $18.32B | $8.80B | $3.69B |
| Net Income (TTM) | $59M | $4.10B | $2.44B | $1.09B | $456M |
| Gross Margin | 44.8% | 36.9% | 52.7% | 52.5% | 68.8% |
| Operating Margin | 15.9% | 14.9% | 19.8% | 19.1% | 17.7% |
| Forward P/E | 30.8x | 20.5x | 21.7x | 36.9x | 20.0x |
| Total Debt | $152M | $34.58B | $13.76B | $3.65B | $1.39B |
| Cash & Equiv. | $40M | $12.49B | $1.54B | $468M | $253M |
THR vs HON vs EMR vs ROK vs TRMB — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Thermon Group Holdi… (THR) | 100 | 407.5 | +307.5% |
| Honeywell Internati… (HON) | 100 | 148.1 | +48.1% |
| Emerson Electric Co. (EMR) | 100 | 231.2 | +131.2% |
| Rockwell Automation… (ROK) | 100 | 207.4 | +107.4% |
| Trimble Inc. (TRMB) | 100 | 158.1 | +58.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: THR vs HON vs EMR vs ROK vs TRMB
Each card shows where this stock fits in a portfolio — not just who wins on paper.
THR is the #2 pick in this set and the best alternative if valuation efficiency is your priority.
- PEG 0.90 vs HON's 11.18
- Lower P/E (30.8x vs 36.9x)
- +136.2% vs TRMB's -6.7%
HON carries the broadest edge in this set and is the clearest fit for income & stability and sleep-well-at-night.
- Dividend streak 15 yrs, beta 0.74, yield 2.1%
- Lower volatility, beta 0.74, current ratio 1.32x
- Beta 0.74, yield 2.1%, current ratio 1.32x
- 7.8% revenue growth vs TRMB's -2.6%
EMR ranks third and is worth considering specifically for growth exposure.
- Rev growth 3.0%, EPS growth 17.8%, 3Y rev CAGR 9.3%
- 13.3% margin vs HON's 11.2%
ROK is the clearest fit if your priority is long-term compounding.
- 341.0% 10Y total return vs THR's 251.9%
- 9.7% ROA vs TRMB's 5.0%, ROIC 15.1% vs 6.8%
Among these 5 stocks, TRMB doesn't own a clear edge in any measured category.
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 7.8% revenue growth vs TRMB's -2.6% | |
| Value | Lower P/E (30.8x vs 36.9x) | |
| Quality / Margins | 13.3% margin vs HON's 11.2% | |
| Stability / Safety | Beta 0.74 vs EMR's 1.52 | |
| Dividends | 2.1% yield, 15-year raise streak, vs EMR's 1.5%, (2 stocks pay no dividend) | |
| Momentum (1Y) | +136.2% vs TRMB's -6.7% | |
| Efficiency (ROA) | 9.7% ROA vs TRMB's 5.0%, ROIC 15.1% vs 6.8% |
THR vs HON vs EMR vs ROK vs TRMB — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
THR vs HON vs EMR vs ROK vs TRMB — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
EMR leads in 1 of 6 categories
HON leads 1 • ROK leads 1 • THR leads 1 • TRMB leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
EMR leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
HON is the larger business by revenue, generating $36.8B annually — 70.4x THR's $522M. Profitability is closely matched — net margins range from 13.3% (EMR) to 11.2% (HON). On growth, ROK holds the edge at +11.8% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $522M | $36.8B | $18.3B | $8.8B | $3.7B |
| EBITDAEarnings before interest/tax | $106M | $6.5B | $4.7B | $1.9B | $785M |
| Net IncomeAfter-tax profit | $59M | $4.1B | $2.4B | $1.1B | $456M |
| Free Cash FlowCash after capex | $55M | $4.2B | $3.1B | $1.3B | $253M |
| Gross MarginGross profit ÷ Revenue | +44.8% | +36.9% | +52.7% | +52.5% | +68.8% |
| Operating MarginEBIT ÷ Revenue | +15.9% | +14.9% | +19.8% | +19.1% | +17.7% |
| Net MarginNet income ÷ Revenue | +11.3% | +11.2% | +13.3% | +12.4% | +12.4% |
| FCF MarginFCF ÷ Revenue | +10.5% | +11.4% | +17.0% | +15.2% | +6.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | +9.6% | -6.9% | +2.9% | +11.8% | +11.8% |
| EPS Growth (YoY)Latest quarter vs prior year | +1.9% | -41.9% | +28.2% | +39.6% | +55.6% |
Valuation Metrics
HON leads this category, winning 3 of 7 comparable metrics.
Valuation Metrics
At 29.4x trailing earnings, HON trades at a 50% valuation discount to ROK's 58.5x P/E. Adjusting for growth (PEG ratio), THR offers better value at 1.21x vs HON's 15.99x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $2.1B | $136.9B | $79.0B | $50.4B | $14.7B |
| Enterprise ValueMkt cap + debt − cash | $2.3B | $159.0B | $91.2B | $53.6B | $15.8B |
| Trailing P/EPrice ÷ TTM EPS | 41.61x | 29.36x | 34.92x | 58.45x | 35.34x |
| Forward P/EPrice ÷ next-FY EPS est. | 30.78x | 20.52x | 21.71x | 36.93x | 20.01x |
| PEG RatioP/E ÷ EPS growth rate | 1.21x | 15.99x | 7.73x | — | 14.39x |
| EV / EBITDAEnterprise value multiple | 22.11x | 19.99x | 18.07x | 30.64x | 20.05x |
| Price / SalesMarket cap ÷ Revenue | 4.31x | 3.66x | 4.39x | 6.04x | 4.08x |
| Price / BookPrice ÷ Book value/share | 4.49x | 9.00x | 3.94x | 13.66x | 2.54x |
| Price / FCFMarket cap ÷ FCF | 40.58x | 25.39x | 29.63x | 37.09x | 110.00x |
Profitability & Efficiency
ROK leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
ROK delivers a 29.6% return on equity — every $100 of shareholder capital generates $30 in annual profit, vs $8 for TRMB. TRMB carries lower financial leverage with a 0.24x debt-to-equity ratio, signaling a more conservative balance sheet compared to HON's 2.24x. On the Piotroski fundamental quality scale (0–9), ROK scores 8/9 vs TRMB's 5/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +10.9% | +23.1% | +12.1% | +29.6% | +8.0% |
| ROA (TTM)Return on assets | +7.2% | +5.3% | +5.8% | +9.7% | +5.0% |
| ROICReturn on invested capital | +9.8% | +12.6% | +8.2% | +15.1% | +6.8% |
| ROCEReturn on capital employed | +12.3% | +12.6% | +10.0% | +18.5% | +7.8% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 6 | 7 | 8 | 5 |
| Debt / EquityFinancial leverage | 0.31x | 2.24x | 0.68x | 0.98x | 0.24x |
| Net DebtTotal debt minus cash | $112M | $22.1B | $12.2B | $3.2B | $1.1B |
| Cash & Equiv.Liquid assets | $40M | $12.5B | $1.5B | $468M | $253M |
| Total DebtShort + long-term debt | $152M | $34.6B | $13.8B | $3.6B | $1.4B |
| Interest CoverageEBIT ÷ Interest expense | 10.25x | 3.92x | 6.46x | 9.06x | 12.26x |
Total Returns (Dividends Reinvested)
THR leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in THR five years ago would be worth $32,890 today (with dividends reinvested), compared to $7,797 for TRMB. Over the past 12 months, THR leads with a +136.2% total return vs TRMB's -6.7%. The 3-year compound annual growth rate (CAGR) favors THR at 45.7% vs HON's 5.1% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +73.6% | +10.9% | +4.3% | +12.8% | -21.0% |
| 1-Year ReturnPast 12 months | +136.2% | +2.8% | +30.4% | +60.2% | -6.7% |
| 3-Year ReturnCumulative with dividends | +209.1% | +16.2% | +75.9% | +65.0% | +30.1% |
| 5-Year ReturnCumulative with dividends | +228.9% | +3.3% | +59.5% | +74.6% | -22.0% |
| 10-Year ReturnCumulative with dividends | +251.9% | +135.1% | +206.6% | +341.0% | +166.8% |
| CAGR (3Y)Annualised 3-year return | +45.7% | +5.1% | +20.7% | +18.2% | +9.2% |
Risk & Volatility
Evenly matched — HON and ROK each lead in 1 of 2 comparable metrics.
Risk & Volatility
HON is the less volatile stock with a 0.74 beta — it tends to amplify market swings less than EMR's 1.52 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ROK currently trades 96.7% from its 52-week high vs TRMB's 70.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.49x | 0.74x | 1.52x | 1.33x | 1.46x |
| 52-Week HighHighest price in past year | $71.24 | $248.18 | $165.15 | $463.49 | $87.50 |
| 52-Week LowLowest price in past year | $23.86 | $186.76 | $108.37 | $277.66 | $61.63 |
| % of 52W HighCurrent price vs 52-week peak | +91.7% | +87.1% | +85.4% | +96.7% | +70.7% |
| RSI (14)Momentum oscillator 0–100 | 77.2 | 45.1 | 61.3 | 74.9 | 36.8 |
| Avg Volume (50D)Average daily shares traded | 553K | 3.7M | 2.8M | 831K | 1.7M |
Analyst Outlook
Evenly matched — HON and EMR each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: THR as "Buy", HON as "Buy", EMR as "Buy", ROK as "Hold", TRMB as "Buy". Consensus price targets imply 53.6% upside for TRMB (target: $95) vs -12.7% for THR (target: $57). For income investors, HON offers the higher dividend yield at 2.14% vs ROK's 1.17%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Hold | Buy |
| Price TargetConsensus 12-month target | $57.00 | $243.83 | $161.92 | $436.56 | $95.00 |
| # AnalystsCovering analysts | 15 | 28 | 41 | 39 | 28 |
| Dividend YieldAnnual dividend ÷ price | — | +2.1% | +1.5% | +1.2% | — |
| Dividend StreakConsecutive years of raises | 2 | 15 | 37 | 20 | — |
| Dividend / ShareAnnual DPS | — | $4.63 | $2.10 | $5.23 | — |
| Buyback YieldShare repurchases ÷ mkt cap | +1.1% | +2.8% | +1.6% | +0.8% | +5.9% |
EMR leads in 1 of 6 categories (Income & Cash Flow). HON leads in 1 (Valuation Metrics). 2 tied.
THR vs HON vs EMR vs ROK vs TRMB: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is THR or HON or EMR or ROK or TRMB a better buy right now?
For growth investors, Honeywell International Inc.
(HON) is the stronger pick with 7. 8% revenue growth year-over-year, versus -2. 6% for Trimble Inc. (TRMB). Honeywell International Inc. (HON) offers the better valuation at 29. 4x trailing P/E (20. 5x forward), making it the more compelling value choice. Analysts rate Thermon Group Holdings, Inc. (THR) a "Buy" — based on 15 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — THR or HON or EMR or ROK or TRMB?
On trailing P/E, Honeywell International Inc.
(HON) is the cheapest at 29. 4x versus Rockwell Automation, Inc. at 58. 5x. On forward P/E, Trimble Inc. is actually cheaper at 20. 0x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Thermon Group Holdings, Inc. wins at 0. 90x versus Honeywell International Inc. 's 11. 18x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — THR or HON or EMR or ROK or TRMB?
Over the past 5 years, Thermon Group Holdings, Inc.
(THR) delivered a total return of +228. 9%, compared to -22. 0% for Trimble Inc. (TRMB). Over 10 years, the gap is even starker: ROK returned +341. 0% versus HON's +135. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — THR or HON or EMR or ROK or TRMB?
By beta (market sensitivity over 5 years), Honeywell International Inc.
(HON) is the lower-risk stock at 0. 74β versus Emerson Electric Co. 's 1. 52β — meaning EMR is approximately 105% more volatile than HON relative to the S&P 500. On balance sheet safety, Trimble Inc. (TRMB) carries a lower debt/equity ratio of 24% versus 2% for Honeywell International Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — THR or HON or EMR or ROK or TRMB?
By revenue growth (latest reported year), Honeywell International Inc.
(HON) is pulling ahead at 7. 8% versus -2. 6% for Trimble Inc. (TRMB). On earnings-per-share growth, the picture is similar: Emerson Electric Co. grew EPS 17. 8% year-over-year, compared to -71. 3% for Trimble Inc.. Over a 3-year CAGR, THR leads at 11. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — THR or HON or EMR or ROK or TRMB?
Emerson Electric Co.
(EMR) is the more profitable company, earning 12. 7% net margin versus 10. 4% for Rockwell Automation, Inc. — meaning it keeps 12. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: EMR leads at 19. 6% versus 16. 0% for THR. At the gross margin level — before operating expenses — TRMB leads at 68. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is THR or HON or EMR or ROK or TRMB more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Thermon Group Holdings, Inc. (THR) is the more undervalued stock at a PEG of 0. 90x versus Honeywell International Inc. 's 11. 18x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Trimble Inc. (TRMB) trades at 20. 0x forward P/E versus 36. 9x for Rockwell Automation, Inc. — 16. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for TRMB: 53. 6% to $95. 00.
08Which pays a better dividend — THR or HON or EMR or ROK or TRMB?
In this comparison, HON (2.
1% yield), EMR (1. 5% yield), ROK (1. 2% yield) pay a dividend. THR, TRMB do not pay a meaningful dividend and should not be held primarily for income.
09Is THR or HON or EMR or ROK or TRMB better for a retirement portfolio?
For long-horizon retirement investors, Honeywell International Inc.
(HON) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 74), 2. 1% yield, +135. 1% 10Y return). Both have compounded well over 10 years (HON: +135. 1%, TRMB: +166. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between THR and HON and EMR and ROK and TRMB?
These companies operate in different sectors (THR (Industrials) and HON (Industrials) and EMR (Industrials) and ROK (Industrials) and TRMB (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
HON, EMR, ROK pay a dividend while THR, TRMB do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.